双重支气管扩展剂加上术前康复在可操作的LC和慢性阻塞性肺病中的作用
Rong Zhou1, Yan Qin2, Song Hu1
1Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Future oncology (London, England)
|November 28, 2024
概括
经手术的双重支气管扩展剂,特别是umeclidinium/vilanterol,改善了非小细胞肺癌 (NSCLC) 慢性阻塞性肺病 (COPD) 患者的呼吸功能和减少了并发症. 这种治疗改善了肺功能和生活质量.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 麻醉学 麻醉学
背景情况:
- 非小细胞肺癌 (NSCLC) 和慢性阻塞性肺病 (COPD) 经常同时存在.
- 这些患者的术后管理具有挑战性,影响结果.
- 双支支气管扩展剂提供了一个潜在的治疗策略.
研究的目的:
- 为了评估经手术期间的双重支气管扩展剂治疗 (umeclidinium/vilanterol) 在患有COPD的NSCLC患者中的疗效.
- 评估对呼吸功能,气体交换和临床结果的影响.
- 为了比较接受双重支气管扩展剂和常规治疗的患者之间的结果.
主要方法:
- 一项前性研究涉及100名中度至重度COPD患者接受胸腔镜叶切除术.
- 患者被随机分配到观察组 (umeclidinium/vilanterol + 传统治疗) 和对照组 (仅使用传统治疗).
- 关键评估包括肺功能测试,动脉血液气体分析,生活质量问卷,以及不良事件和恢复指标的监测.
主要成果:
- 与对照组相比,umeclidinium/vilanterol组的FEV1,FVC,PEF和MVV显著改善.
- 在治疗组中观察到高的PO2和降低的PCO2水平.
- 治疗组的副作用较少,胸管安置和住院时间较短.
结论:
- 在外科手术期间使用umeclidinium/vilanterol可以有效地保持动脉血气值和呼吸功能.
- 双重支气管扩展剂治疗对接受手术的伴随性COPD的NSCLC患者有益.
- 这种方法改善了外科手术期间的结果和患者的康复.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
179
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K